Insulin resistance and body composition in preterm born children during prepubertal ages

Feyza Darendeliler1, Firdevs Bas, Ruveyde Bundak

  • 1Pediatric Endocrinology Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. feyzad@istanbul.edu.tr

Clinical Endocrinology
|November 6, 2007
PubMed

Insights

Premature infants born appropriate for gestational age (AGA) and small for gestational age (SGA) do not exhibit insulin resistance if they achieve catch-up growth. Intrauterine growth restriction, not prematurity itself, impacts future metabolic health.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Growth and Development

Background:

  • Premature infants may develop childhood insulin resistance due to intrauterine or postnatal environmental factors.
  • Understanding the metabolic consequences of prematurity and growth patterns is crucial for long-term health.
  • Insulin resistance in childhood can have significant implications for metabolic and cardiovascular health.

Purpose of the Study:

  • To evaluate insulin resistance and body composition in preterm infants born AGA or SGA.
  • To examine the relationship between insulin resistance, body composition, and the IGF-I/IGFBP-3 axis in preterm children.
  • To compare metabolic and body composition parameters between preterm and term-born children.

Main Methods:

  • Ninety-three preterm children (SGA and AGA) and 86 term-born children (SGA and AGA) were assessed at approximately 4 years of age.
  • Measurements included glucose, insulin, IGF-I, IGFBP-3, IGFBP-1, leptin levels, and body composition via dual-energy X-ray absorptiometry.
  • Insulin resistance was determined using basal insulin levels and the homeostasis model assessment for insulin resistance (HOMA-IR).

Main Results:

  • Preterm AGA and SGA children with catch-up growth and normal BMI did not show increased insulin resistance compared to term-born peers.
  • Term SGA children exhibited significantly higher insulin levels and HOMA-IR compared to preterm SGA children.
  • IGF-I levels were lower in preterm AGA children than in term AGA children, while body composition and leptin levels did not differ significantly between groups.

Conclusions:

  • Premature infants achieving appropriate catch-up growth and normal BMI do not present with insulin resistance.
  • Elevated insulin levels in term SGA children suggest that third-trimester intrauterine growth restriction adversely affects future metabolic outcomes.
  • The findings highlight the importance of catch-up growth in mitigating metabolic risks associated with prematurity.
Abstract

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...